Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedProstate cancer and related topics were added to the page, including a link to MedlinePlus Genetics in the related topics section. This expands the disease context and provides quick access to additional genetics resources related to the study.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag was updated from v3.6.5 to v3.6.6, indicating a new build or update to the page. No study details or user-facing content are altered by this change.SummaryDifference0.1%

- Check23 days agoChange DetectedRemoved the explicit reference to 'Prostate cancer' and the 'Related topics' section, including the 'MedlinePlus Genetics' link. This alters the page's disease context and access to a genetics resources section.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 500 error screen stating that the page is currently unavailable, replacing the study record content with a generic error message.SummaryDifference17%

- Check51 days agoChange DetectedThe page shows a new site revision tag (v3.6.4) replacing the previous v3.6.3, indicating a minor update to the site's backend or templates and no change to the study details.SummaryDifference0.1%

- Check73 days agoChange DetectedThe footer revision label updated from v3.6.2 to v3.6.3, signaling a minor site update to the page rendering without changing study information.SummaryDifference0.1%

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.